Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Long Non-Coding Rnas: Potential Players in Cardiotoxicity Induced by Chemotherapy Drugs Publisher Pubmed



Amrovani M1 ; Mohammadtaghizadeh M2 ; Aghaali MK3 ; Zamanifard S4 ; Alqasi A5 ; Sanei M6
Authors

Source: Cardiovascular Toxicology Published:2022


Abstract

One of the most important side effects of chemotherapy is cardiovascular complications, such as cardiotoxicity. Many factors are involved in the pathogenesis of cardiotoxicity; one of the most important of which is long non-coding RNAs (lncRNAs). lncRNA has 200–1000 nucleotides. It is involved in important processes such as cell proliferation, regeneration and apoptosis; today it is used as a prognostic and diagnostic factor. A, various drugs by acting on lncRNAs can affect cells. Therefore, by accurately identifying IncRNAs function, we can play an effective role in preventing the development of cardiotoxicity-induced chemotherapy drugs, and use them as a therapeutic strategy to improve clinical symptoms and increase patient survival. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Related Docs
View other Related Docs
1. Role of Long Noncoding Rnas in Pathological Cardiac Remodeling After Myocardial Infarction: An Emerging Insight Into Molecular Mechanisms and Therapeutic Potential, Biomedicine and Pharmacotherapy (2024)
2. Epigenetic Regulation in Myocardial Infarction: Non-Coding Rnas and Exosomal Non-Coding Rnas, Frontiers in Cardiovascular Medicine (2022)
3. Long Non-Coding Rnas in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-Of-The-Art Review, Frontiers in Oncology (2021)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (1)
Nima Rezaei (1)
Other Related Docs
4. Crosstalk Between Lncrnas in the Apoptotic Pathway and Therapeutic Targets in Cancer, Cytokine and Growth Factor Reviews (2022)
5. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
6. An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers, Pathology Research and Practice (2023)
7. Non-Coding Rnas and Glioblastoma: Insight Into Their Roles in Metastasis, Molecular Therapy Oncolytics (2022)
8. Competing Endogenous Rnas Regulatory Crosstalk Networks: The Messages From the Rna World to Signaling Pathways Directing Cancer Stem Cell Development, Heliyon (2024)
9. Autophagy and Gastrointestinal Cancers: The Behind the Scenes Role of Long Non-Coding Rnas in Initiation, Progression, and Treatment Resistance, Cancer Gene Therapy (2021)
10. New Insights Into the Long Non-Coding Rnas Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment, Current Medicinal Chemistry (2024)
11. Modulation of Long Non-Coding Rnas by Resveratrol As a Potential Therapeutic Approach in Cancer: A Comprehensive Review, Pathology Research and Practice (2023)
12. Long Noncoding Rnas and Exosomal Lncrnas: Classification, and Mechanisms in Breast Cancer Metastasis and Drug Resistance, Oncogene (2020)
13. Lncrna-Mediated Regulation of Cisplatin Response in Breast Cancer, Pathology, research and practice (2024)
14. The Role of Long Noncoding Rnas (Lncrnas) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective, Indian Journal of Gynecologic Oncology (2025)
15. Combination Meg3 Lncrna and Ciprofloxacin Dramatically Decreases Cell Migration and Viability As Well As Induces Apoptosis in Gc Cells in Vitro, Biotechnology and Applied Biochemistry (2024)
16. Evaluation of Mir-146A As a Potential Biomarker for Diagnosis of Cardiotoxicity Induced by Chemotherapy in Patients With Breast Cancer, Journal of Research in Medical Sciences (2025)
17. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)
18. Down-Regulation of a Panel of Immune-Related Lncrnas in Breast Cancer, Pathology Research and Practice (2021)
19. Long Non-Coding Rnas and Melanoma: From Diagnosis to Therapy, Pathology Research and Practice (2023)
20. Modulation of Long Non-Coding Rnas and Micrornas by Quercetin As a Potential Therapeutical Approach in Cancer: A Comprehensive Review, Current Medicinal Chemistry (2025)